MPM BioVentures 2014, L.P. sold TRDA
August 28, 2026 · Form 4 insider transaction
MPM BioVentures 2014, L.P. sold 3,733 shares of Entrada Therapeutics, Inc. at $7.01 per share, a transaction worth $26.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
The shares were sold as follows: 1,695 by BV 2014, 113 by BV 2014(B), 58 by AM BV2014, 1,740 by BV 2018, 93 by BV 2018(B) and 34 by AM BV2018.; Price represents the weighted average sale price of the shares sold. The sale price ranged from $6.95 to $7.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.; Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.; The shares are held as follows: 1,941,522 by BV 2014, 129,496 by BV 2014(B), 66,828 by AM BV2014, 1,992,615 by BV 2018, 105,905 by BV 2018(B) and 39,327 by AM BV2018.